Suppr超能文献

同种异体骨作为抗生素载体。

Allograft Bone as Antibiotic Carrier.

作者信息

Winkler Heinz, Haiden Peter

机构信息

Osteitis Centre, Privatklinik Döbling Wien, Heiligenstaedter Strasse 57-63, A-1190 Wien, AUSTRIA.

Department of Traumatology, Landesklinikum Korneuburg, Wiener Ring 3-5, 2100 Korneuburg, AUSTRIA.

出版信息

J Bone Jt Infect. 2017 Jan 1;2(1):52-62. doi: 10.7150/jbji.17466. eCollection 2017.

Abstract

The treatment of chronic bone and joint infections is characterized by obstinate persistency of the causing microorganisms and resulting long term disability to patients, associated with remarkable costs for the health care system. Difficulties derive from biofilm formed on dead bone and eventual implants, with resistance against immunological defences and antimicrobial substances. Biofilm embedded bacteria require up to 1000 times the antibiotic concentration of planktonic bacteria for elimination. Systemic antibiotic treatment alone cannot provide the concentrations required and surgical intervention is always prerequisite for potentially providing a cure. A second issue is that osseous defects are almost always present after surgical debridement, and it is difficult to address their reconstruction. One option is to use bone grafts, either from the patient´s own body or from foreign donors (allografts). Grafts are usually unvascularized and are prone to colonization with bacteria. Loading of allografts with antibiotics may not only protect grafts from bacterial adhesion but, using appropriate processing methods, may also provide high local antibiotic concentrations that may eliminate remaining sessile pathogens. For efficient action as antibiotic carriers, the release of antibiotics should be above the minimum biofilm eradication concentration (MBEC) for a prolonged period of time. Cleaning the bone from bone marrow opens a large reservoir for storage of antimicrobial substances that, after implantation, may be released to the surrounding in a sustained mode, possibly eliminating remaining biofilm remnants. Removal of bone marrow, leaving a pure matrix, provides increased safety and improved revascularization of the graft. Local provision of antibiotic concentrations above the MBEC may enable simultaneous internal fixation with osteosynthetic material and single stage exchange of infected endoprostheses, resulting in shorter hospital stays with reduced pain and faster rehabilitation of patients.

摘要

慢性骨与关节感染的治疗特点是致病微生物顽固持续存在,给患者带来长期残疾,同时给医疗保健系统带来高昂费用。困难源于死骨和最终植入物上形成的生物膜,其对免疫防御和抗菌物质具有抗性。嵌入生物膜的细菌消除所需的抗生素浓度是浮游细菌的1000倍。仅全身抗生素治疗无法提供所需浓度,手术干预始终是实现治愈的先决条件。第二个问题是手术清创后几乎总会出现骨缺损,且难以解决其重建问题。一种选择是使用骨移植,要么取自患者自身身体,要么取自异体供体(同种异体移植物)。移植物通常无血管,容易被细菌定植。在同种异体移植物中加载抗生素不仅可以保护移植物免受细菌黏附,而且使用适当的处理方法,还可以提供高局部抗生素浓度,可能消除残留的固着病原体。为了作为抗生素载体有效发挥作用,抗生素的释放应在较长时间内高于最低生物膜根除浓度(MBEC)。清除骨髓中的骨可为抗菌物质的储存开辟一个大的储存库,植入后抗菌物质可持续释放到周围环境中,可能消除残留的生物膜残余物。去除骨髓,留下纯净基质,可提高移植物的安全性并改善其血管再生。局部提供高于MBEC的抗生素浓度可实现与骨合成材料同时进行内固定以及感染假体的单阶段置换,从而缩短住院时间,减轻疼痛并加快患者康复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6bb/5423575/56cd97c6c35b/jbjiv02p0052g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验